|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A randomized phase Ⅱ study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer显示文摘 | Arlen PM Gulley JL Parker C | 2006 | Clin Cancer Res2006，12，4： | 1 |
| 2 | Strategies for the development of PSA-based vaccines for the treatment of advanced prostate cancer显示文摘 | Arlen PM Culley JL Tsang KY | 2003 | Expert Rev Vaccines2003，2，4： | 1 |
| 3 | Randomized phase Ⅱ trial of docetaxel plus thalidomide in androgen-independent prostate cancer显示文摘 | Dabut WL Gulley JL Arlen PM | 2004 | J Clin Oncol2004，22，13： | 1 |
| 4 | Phase II trial ofbevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer显示文摘 | Ning YM Gulley JL Arlen PM | 2010 | J Clin Oncol2010，2028，12： | 1 |
| 5 | Cancer vaccines: moving beyond current paradigms 显示文摘 | SCHLOM J ARLEN PM GULLEY JL | 2007 | Clin Cancer Res2007，13，13： | 1 |
| 6 | Cancer vaccines: moving beyond current paradigms 显示文摘 | Schlom J Arlen PM Gulley JL | 2007 | Clin Cancer Res2007，3，： | 1 |
| 7 | Randomised phase Ⅱ trial of docetaxel plus thalidomide in androgen-independent prosrate cancer 显示文摘 | Dahut WL Gulley JL Arlen PM | 2004 | J Clin Oncol2004，22，13： | 1 |
| 8 | Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma显示文摘 | Gulley JL Arlen PM Tsang KY | | 0，，： | 1 |
| 9 | Randomized phase Ⅱ trim of docetaxel plus thalidomide in androgen-independent prostate cancer显示文摘 | Dahut WL Gulley JL Arlen PM | 2004 | J Clin Oncol2004，22，13： | 1 |
| 10 | Phase II trial of bevacizum- ab, thalidomide, docetaxel, and prednisone in patients with meta- static castration - resistant prostate cancer 显示文摘 | Ning YM Gulley JL Arlen PM | 2010 | J Clin Oncol2010，28，12： | 1 |
| 11 | Multiple myeloma after treatment of essential thrombocythemia显示文摘 | Arlen PM Goldkland GA | 1995 | South Med J1995，88，1： | 1 |
| 12 | Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-mac- rophage colony-stimulating factor, in patients with carcinoembwonic antigen-expressing carcinomas显示文摘 | Marshall JL Gulley JL Arlen PM | 2005 | J Clin Oncol2005，23，4： | 1 |
| 13 | A randomized phase Ⅱ study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer显示文摘 | Arlen PM Gulley JL Parker C | 2006 | Clin Cancer Res2006，12，4： | 1 |
| 14 | Randomized phase II Trial of docetaxel plus thalidomide in androgen-inde- pendent prostate cancer 显示文摘 | DAHUT WL GULLEY JL ARLEN PM | 2004 | J Clin Oncol2004，22，13： | 1 |
| 15 | A randomized phase Ⅱ study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen independent prostate cancer显示文摘 | Arlen PM Gulley JL Parker C | | Clin Cancer Res0，12，4： | 1 |
| 16 | Phase Ⅰ study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA ( 6D )-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas显示文摘 | MARSHALL JL GULLEY JL ARLEN PM | 2005 | J Clin Oncol2005，23，4： | 1 |
| 17 | Cancer vaccines:moving beyond current paradigms显示文摘 | Schlom J Arlen PM Gulley JL | | 0，，13： | 1 |
| 18 | Randomized phaseⅡtrial of docetaxel plus thalidomide in androgen-independent prostate cancer显示文摘 | Dahut WL Gulley JL Arlen PM | 2004 | JClin Onco2004，22，13： | 1 |
| 19 | Enhancing efficacy of therapeutic vaccinations by combination with other modalities显示文摘 | Gulley JL Madan RA Arlen PM | | 0，，2： | 1 |
| 20 | Phase Ⅰ study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM,with and without granulocyte-macrophage colony-stimulating factor,in patients with carcinoembryonic antigen-expressing carcinomas显示文摘 | Marshall JL Gulley JL Arlen PM Beetham PK Tsang KY Slack R | 2005 | J Clin Oncol2005，23，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员